基于卵黄蛋白原功能域的重组疫苗对大西洋鲑抗虱疮痂鱼虱的保护与免疫刺激作用
本研究评估了基于两种虱疮痂鱼虱卵黄蛋白原von Willebrand因子域(CrVtg-VWF1和CrVtg-VWF2)的重组疫苗对大西洋鲑的控制效果。180尾大西洋鲑分别免疫后,在免疫后400度日以每尾35个桡足幼体攻毒。攻毒后7天,疫苗组chalimus I附着减少约12%;攻毒后21天,CrVtg-VWF1和CrVtg-VWF2相对对照组的 efficacy 分别为40.2%和53.4%。CrVtg-VWF抗原主要显著上调头肾组织中MHC II、IgM和IgT转录本。
要点
- 基于CrVtg-VWF1和CrVtg-VWF2的重组疫苗可降低大西洋鲑鱼虱负荷。
- 攻毒后21天,CrVtg-VWF2疫苗 efficacy 达53.4%,高于CrVtg-VWF1的40.2%。
- 疫苗可显著上调头肾MHC II、IgM和IgT转录本,提示免疫刺激作用。
核心结论
- 基于VWF域的重组疫苗对控制大西洋鲑虱疮痂鱼虱感染具有潜力。
研究设计与样本
- 研究将两种CrVtg-VWF重组蛋白域分别制成实验疫苗,免疫180尾大西洋鲑,免疫后400度日以每尾35个桡足幼体攻毒。
- 攻毒后7天和21天评估寄生虫负荷,并检测皮肤和头肾组织免疫相关基因表达。
主要发现
- 攻毒后7天,疫苗组chalimus I附着减少约12%。
- 攻毒后21天,CrVtg-VWF1组 efficacy 为40.2%,CrVtg-VWF2组为53.4%,均相对对照组。
- CrVtg-VWF抗原主要显著上调头肾组织中MHC II、IgM和IgT转录本, compared with control group。
关键数值与推荐
- 攻毒后7天,chalimus I附着减少约12%。
- 攻毒后21天,CrVtg-VWF1 efficacy 为40.2%,CrVtg-VWF2为53.4%。
临床怎么用
- 该疫苗策略可能作为水产养殖中减少杀虱药物依赖的可持续控制手段。
- 免疫后需在攻毒后21天评估成虫期保护效果,并关注头肾免疫基因上调。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sea lice cause economic losses in global salmon aquaculture, and the treatments used, mainly delousing drugs, have become less effective. Thus, moving forward, developing new, sustainable control strategies is required. In this context, our study evaluated the use of a recombinant vaccine for controlling sea lice. The von Willebrand factor domains (VWF) from two Caligus rogercresseyi vitellogenins (CrVtg), CrVtg-VWF1 and CrVtg-VWF2, were selected for immunization and challenge in Atlantic salmon. In silico analyses confirmed the immunogenic potential of these domains. The recombinant protein domains were incorporated into experimental vaccine formulations, separately. A total of 180 Atlantic salmon were immunized and subsequently challenged with 35 copepodids per fish after 400 degree-days post-vaccination. At 7- and 21 days post-infestation (dpi), vaccine efficacy was evaluated based on parasite load quantification. Moreover, the expression of immune-related genes was evaluated in fish skin and head kidney tissues. At 7 dpi, chalimus I attachment was reduced by approximately 12% in the vaccinated groups, in the case of adults, 21 dpi, the efficacy was 40.2% for CrVtg-VWF1 and 53.4% for CrVtg-VWF2, relative to the control group. Moreover, CrVtg-VWF antigens primarily stimulated significant upregulation of MHC II, IgM, and IgT transcripts in the head kidney tissue compared with the control group. These results demonstrate the potential of VWF domain-based vaccines as a novel approach for controlling sea lice infestations in Atlantic salmon.
引用
- Casuso A, Rodríguez-Gabilondo A, Leal Y, et al. Protective and immunostimulatory effects of a vitellogenin functional domain-based vaccine in Atlantic salmon against Caligus rogercresseyi. Vaccine. 2026. PMID: 42600248. doi:10.1016/j.vaccine.2026.129025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。